12 Penny Stocks with Insider Buying in 2026
The CEO of Wealth Consulting Group, Jimmy Lee, told BNN Bloomberg on March 25 that as conditions calm, the ongoing geopolitical crises in the Middle East may eventually present investors with selective...
Niagen Bioscience Inc. (NAGE)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,616,752 | $10,282,543 | +13% | 0.01% |
| 2. | Renaissance Technologies Jim Simons | 914,118 | $5,813,790 | +29% | 0.01% |
| 3. | AQR Capital Management Cliff Asness | 605,954 | $3,853,867 | +4% | 0% |
| 4. | Millennium Management Israel Englander | 561,110 | $3,568,660 | -28% | 0% |
| 5. | Trexquant Investment LP Tyger (Taesoon) Park | 436,332 | $2,775,072 | -2% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.85 | 2,220 | $15,210.03 | 2,220 | 2025-11-14 | Filing | |
| $6.81 | 4,465 | $30,406.39 | 7,372 | 2025-11-14 | Filing | |
| $7.86 | 273 | $2,145.78 | 2,251 | 2025-03-07 | Filing | |
| $7.36 | 2,907 | $21,396.97 | 2,907 | 2024-11-22 | Filing | |
| $0.00 | 11,408,715 | $0.00 | 19,294,356 | 2024-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.19 | 37,161 | $229,955.98 | 244,179 | 2024-12-13 | Filing | |
| $3.57 | 23,000 | $82,110.00 | 0 | 2024-08-23 | Filing | |
| $0.00 | 11,408,715 | $0.00 | 0 | 2024-08-20 | Filing | |
| $13.17 | 20,000 | $263,400.00 | 16,667 | 2021-03-16 | Filing | |
| $11.15 | 32,500 | $362,375.00 | 16,667 | 2021-03-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,075,709 | $25,921,508 | 0% | |
| 2. | 3,286,498 | $20,902,127 | 0% | |
| 3. | 1,411,742 | $8,978,679 | 0% | |
| 4. | 1,294,863 | $8,237,043 | 0% | |
| 5. | 1,091,039 | $6,939,008 | 0% |
News See All
Niagen Bioscience Inc (NASDAQ:NAGE) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Niagen Bioscience, Inc. Fourth Quarter of 2025 Earnings Conference Call.
Niagen Bioscience, Inc. (NAGE): A Bull Case Theory
We came across a bullish thesis on Niagen Bioscience, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on NAGE.
Niagen Bioscience Inc (NASDAQ:NAGE) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Niagen Biosciences, Inc. Third Quarter of 2025 Earnings Conference Call.
Niagen Bioscience Inc (NASDAQ:NAGE) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Niagen Biosciences Inc. First Quarter of 2025 Earnings Conference Call.
Hedge Fund Resource Center